Annual Current Ratio
29.27
+10.66+57.28%
December 31, 2023
Summary
- As of February 7, 2025, AKRO annual current ratio is 29.27, with the most recent change of +10.66 (+57.28%) on December 31, 2023.
- During the last 3 years, AKRO annual current ratio has risen by +8.57 (+41.40%).
- AKRO annual current ratio is now -11.11% below its all-time high of 32.93, reached on December 31, 2018.
Performance
AKRO Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
17.25
-7.64-30.70%
September 30, 2024
Summary
- As of February 7, 2025, AKRO quarterly current ratio is 17.25, with the most recent change of -7.64 (-30.70%) on September 30, 2024.
- Over the past year, AKRO quarterly current ratio has dropped by -3.00 (-14.81%).
- AKRO quarterly current ratio is now -49.87% below its all-time high of 34.41, reached on June 30, 2019.
Performance
AKRO Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
AKRO Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +57.3% | -14.8% |
| 3 y3 years | +41.4% | +83.1% |
| 5 y5 years | -11.1% | -22.7% |
AKRO Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +280.1% | -42.7% | +150.0% |
| 5 y | 5-year | at high | +280.1% | -42.7% | +150.0% |
| alltime | all time | -11.1% | +919.9% | -49.9% | +150.0% |
Akero Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 17.25(-30.7%) |
| Jun 2024 | - | 24.89(-17.4%) |
| Mar 2024 | - | 30.12(+2.9%) |
| Dec 2023 | 29.27(+57.3%) | 29.27(+44.5%) |
| Sep 2023 | - | 20.25(-32.0%) |
| Jun 2023 | - | 29.78(+42.9%) |
| Mar 2023 | - | 20.84(+12.0%) |
| Dec 2022 | 18.61(+141.7%) | 18.61(+24.3%) |
| Sep 2022 | - | 14.97(+117.0%) |
| Jun 2022 | - | 6.90(-9.2%) |
| Mar 2022 | - | 7.60(-1.3%) |
| Dec 2021 | 7.70 | 7.70(-18.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | 9.42(-34.4%) |
| Jun 2021 | - | 14.35(-43.1%) |
| Mar 2021 | - | 25.23(+21.9%) |
| Dec 2020 | 20.70(+40.5%) | 20.70(-16.6%) |
| Sep 2020 | - | 24.81(+127.8%) |
| Jun 2020 | - | 10.89(-28.5%) |
| Mar 2020 | - | 15.23(+3.4%) |
| Dec 2019 | 14.73(-55.3%) | 14.73(-34.0%) |
| Sep 2019 | - | 22.32(-35.1%) |
| Jun 2019 | - | 34.41(+17.0%) |
| Mar 2019 | - | 29.41(-10.7%) |
| Dec 2018 | 32.93(+1047.4%) | 32.93 |
| Dec 2017 | 2.87 | - |
FAQ
- What is Akero Therapeutics annual current ratio?
- What is the all time high annual current ratio for Akero Therapeutics?
- What is Akero Therapeutics annual current ratio year-on-year change?
- What is Akero Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Akero Therapeutics?
- What is Akero Therapeutics quarterly current ratio year-on-year change?
What is Akero Therapeutics annual current ratio?
The current annual current ratio of AKRO is 29.27
What is the all time high annual current ratio for Akero Therapeutics?
Akero Therapeutics all-time high annual current ratio is 32.93
What is Akero Therapeutics annual current ratio year-on-year change?
Over the past year, AKRO annual current ratio has changed by +10.66 (+57.28%)
What is Akero Therapeutics quarterly current ratio?
The current quarterly current ratio of AKRO is 17.25
What is the all time high quarterly current ratio for Akero Therapeutics?
Akero Therapeutics all-time high quarterly current ratio is 34.41
What is Akero Therapeutics quarterly current ratio year-on-year change?
Over the past year, AKRO quarterly current ratio has changed by -3.00 (-14.81%)